logo

Cellect Biotechnology Ltd. (APOP)



Trade APOP now with
  Date
  Headline
8/13/2019 8:08:21 AM Cellect Biotechnology Q2 Net Loss $0.23 Mln Or $0.02/ADS Vs. Loss $1.64 Mln Or $0.26/ADS Last Year
5/21/2019 7:12:15 AM Cellect Biotechnology Q1 Net Loss $1.4 Mln Vs. Net Loss $1.03 Mln Last Year
5/16/2019 7:41:04 AM Cellect Biotechnology To Explore Strategic Alternatives To Maximize Shareholder Value
3/27/2019 8:03:58 AM Cellect Announces Positive Phase I/II Mid-Study Results Of ApoGraft Technology
3/11/2019 7:09:30 AM Cellect Announces Positive Preliminary Results From Collaboration With Cell2in On Improving Quality Of Stem Cells
2/8/2019 1:02:11 AM Cellect Announces Pricing Of Public Offering Of 1.889 Mln Units
1/28/2019 7:09:50 AM Cellect Biotechnology Concludes Scale-up Development And Manufacturing Of Clinical Grade FasL
1/23/2019 7:23:09 AM Cellect Biotechnology Announces Clinical And Regulatory Milestone Targets
11/5/2018 7:08:47 AM Cellect Biotechnology Receives Multiple Patent Grants
10/18/2018 7:16:38 AM Cellect Biotechnology Reports Positive Results Of Orthopedic Treatment With Use Of ApoGraft
10/15/2018 7:20:08 AM Cellect Biotechnology Announces Positive Data From Phase I/II Study Of ApoGraft Technology
7/5/2018 7:04:11 AM Cellect Biotechnology Signs Collaboration Agreement With Dresden University DenovoMATRIX Team
4/9/2018 7:16:31 AM Cellect Biotechnology Reports Major Milestone For Enabling Stem Cells Production
1/4/2018 8:04:17 AM Cellect Heralds Stem Cell Breakthrough, Shares Skyrocket